About 6 results found for searched term "Aspirin" (0.146 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5426 | Aspirin | Animal Modeling |
| Acetylsalicylic acid | ||
| Aspirin is a salicylate, and irreversible COX1 and COX2 inhibitor, used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. | ||
| M8335 | NCX 4040 | Apoptosis |
| NCX4040; NO-Aspirin | ||
| NCX4040 (NO-Aspirin) is a nitric oxide-donating form of aspirin, and a non-steroidal anti-inflammatory agent. NCX4040 induces apoptosis in PC3 metastatic prostate cancer cells. | ||
| M8606 | NCX 4016 | Others |
| NCX 4016 (nitroaspirin) is nitroderivative of aspirin that combines cyclooxygenase inhibitor with an NO donor. | ||
| M9712 | Pyrocatechuic acid | Metabolite/Endogenous Metabolite |
| 2,3-Dihydroxybenzoic acid; Catecholcarboxylic acid; NSC 27435 | ||
| Pyrocatechuic acid (2,3-Dihydroxybenzoic acid) is a normal human benzoic acid metabolite found in plasma, and has increased levels after aspirin ingestion. | ||
| M30291 | Resolvin E1 | Metabolite/Endogenous Metabolite |
| RvE1 | ||
| Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production. | ||
| M42949 | Methyl 2-acetoxybenzoate | Others |
| Methyl 2-acetoxybenzoate (Methyl acetylsalicylate) is a safe and simple anti-inflammatory aspirin precursor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
